digiMedical Solutions, Inc. Signs Contract With Advanced Gastroenterology to Implement Microsoft-Based Digital Prescription Technology as Company Continues to Expand Sales in Florida

COLLEYVILLE, TX--(Marketwire - May 8, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that the Company has signed a contract with Dr. Shardul Nanavati, founder of Advanced Gastroenterology of Naples, Florida (http://naplesgastro.com/home_gastro.shtml). digiMedical will implement the Company's Microsoft-based digital prescription handling software, digiRX and digiReauth, and will supply call center services to support the reauthorization of prescriptions. Dr. Nanavati graduated with honors from Johns Hopkins University and completed his medical degree at University of Vermont College of Medicine. Dr. Nanavati, a member of the American Gastroenterologic Association, American College of Gastroenterology, American Medical Association and Collier Medical Society, is a digestive disease specialist.

Multiple Doctors to Implement digiMedical Digital Prescription Software

Each new doctor contract can add hundreds of patients to the digiRX network, who in turn drive prescription sales into company owned pharmacies and increase company revenue. digiMedical is actively expanding their regional footprint in the Naples area in support of the 2008 revenue goal of $10 million.

This contract follows multiple other recent contracts with doctors in the area, to include Dr. Moorthy of Pain Management Center of Naples, Dr. Albert A. Alessi of Alessi Family Care, Drs. Romero, Tineo and Seibert of Oaktree Family Practice, Orthopedic Surgeon Dr. Howard Kapp of Anchor Health Centers, Drs. Santos-Ocampo, Axline and Spilker of the Collier Heart Group, the Medical Director of Vanish Vein and Laser Center and Dr. Wey of the Neuroscience and Spine Associates in Naples, Florida.

digiMedical Prescription Handling Software and Pharmacies

digiMedical Solutions, a Microsoft Partner, with operations in Texas and Florida, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now digiAccounting and the Company owns and operates five pharmacies throughout Texas and Florida.

Company Fact Sheet and Updates

To be added to digiMedical's corporate e-mail list for shareholders and interested investors or to receive a Fact Sheet on the company, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc.™

digiMedical Solutions, Inc.™ (www.digimedical.com) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless base d-prescription technology to doctors, acquisition of independent pharmacy chains and the sale of certain territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.™ currently owns and operates five (5) pharmacies located in Texas and Florida. digiMedical Solutions'™ unique business model brings doctor, patients and pharmacies into next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as ``Forward-Looking Statements'' for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward Looking Statements may be identified by words including "anticipate,'' "await,'' "envision,'' "foresee,'' "aim at,'' "believe,'' "intends,'' "estimates'' including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact Information: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029